Degree of mitral regurgitation and left ventricular scarring are more powerful predictors of long-term outcomes than volumes and sphericity: a multi-modality imaging study in patients with severe ischemic cardiomyopathy by Deborah Kwon et al.
BioMed Central
Journal of Cardiovascular Magnetic 
Resonance
ssOpen AcceOral presentation
Degree of mitral regurgitation and left ventricular scarring 
are more powerful predictors of long-term outcomes than volumes 
and sphericity: a multi-modality imaging study in patients with 
severe ischemic cardiomyopathy
Deborah Kwon*, Zoran B Popovic, Venugopal Menon, Carmel M Halley, 
Danielle Brennan, Randall C Starling, Scott D Flamm, Paul Schoenhagen, 
Bruce W Lytle, Brian P Griffin and Milind Y Desai
Address: Cleveland Clinic Foundation, Cleveland, OH, USA
* Corresponding author    
Background
Patients with ischemic cardiomyopathy (ICM) and severe
left ventricular (LV) systolic dysfunction exhibit adverse
left ventricular (LV) remodeling, with increasing spheric-
ity, which predicts long-term mortality. Myocardial scar-
ring, measured accurately by delayed hyperenhancement
cardiac magnetic resonance (DHE-CMR), and mitral
regurgitation (MR), also predicts outcomes in such
patients.
Objective
In patients with severe ICM, we sought to assess the
impact of LV sphericity, myocardial scarring (both meas-
ured on CMR) and MR (measured on Doppler echocardi-
ography), on long-term survival.
Methods
Patients (n = 326) with > 70% disease in ≥ 1 epicardial
coronary artery (77% men, median age 66 years and
median LV ejection fraction or EF of 22%) undergoing
Doppler echocardiography and CMR (Siemens 1.5-T
scanner, Erlangen, Germany) were studied. CMR evalua-
tion included long and short axis assessment of LV func-
tion on balanced steady state free precession images along
with assessment of myocardial scar (on phase-sensitive
inversion recovery DHE-CMR sequence ~10-20 minutes
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mine). Scar was measured automatically measured as > 2
SD above viable myocardium. LV scar score (defined as
summed segmental scar score per patient divided by 17,
with maximum being 4) was recorded on DHE-CMR
images as: 0 = none, 1 = 1-25%, 2 = 26-50%, 3 = 51-75%,
and 4 = > 75%; and subdivided into 7 anterior, 5 inferior
and 5 lateral segments. LV volumes and LV ejection frac-
tion were calculated. LV sphericity was measured on end-
diastolic 4-chamber cine view as D1+D2+D3/3L (Figure
1). LV volumes and sphericity was indexed to body surface
area. Vena contracta (cm) was measured on Doppler
Table 1: 
Univariable Analysis
Hazard ratio (CI) p-value
Clinical variables
Age 1.03 (1.01-1.05 0.001
Female Gender 2.00 (1.31-3.07) 0.002
Diabetes Mellitus 1.26 (0.82-1.940 0.3
Hypertension 0.95 (0.62-1.46) 0.8
Statins 0.74 (0.49-1.12) 0.1
Beta-blockers 0.71 (0.47-1.06) 0.1
Angiotensin converting enzyme-inhibitors 0.75 (0.49-1.14) 0.2
Aldosterone antagonists 1.17 (0.74-1.86) 0.5
Post-CMR coronary bypass grafting 0.62 (0.41-0.93) 0.02
Post-CMR mitral valve repair/replacement 1.10 (0.68-1.79) 0.7
Post-CMR defibrillator/resynchronization therapy 0.73 (0.45-1.20) 0.2
Echocardiographic variables
Vena contracta 5.70 (2.94-11.04) < 0.001
CMR variables
LV ejection fraction 0.98 (0.96-1.003) 0.1
LV end-diastolic volume index 1.004 (0.99-1.008) 0.1
Indexed left atrial volume 1.006 (0.99-1.02) 0.3
Indexed (D1+D2+D3)/3L (cm/m2) 1.23 (1.06-1.44) 0.007
Semiquantitative total scar score 1.21 (1.00-1.46) 0.04
Semiquantitative regional scar score
Anterior 1.06 (0.90-1.23) 0.5a
Lateral 1.13 (0.97-1.31) 0.1
Inferior 1.24 (1.06-1.44) 0.008Page 2 of 3
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echocardiography. A composite end-point of cardiac
transplantation and all-cause mortality was recorded.
Results
Over a follow-up of 4.0 years [interquartile range 2.6, 5.1],
there were 92 events (87 deaths and 5 cardiac transplanta-
tions). Results of Univariable Cox Proportional survival
analysis are shown in Table 1. However, on multivariable
survival analysis, only age (hazard ratio or HR 1.04 [1.02-
1.06], p < 0.001), gender (HR 2.04 [1.33-3.14], p <
0.001), vena contracta (HR 4.60 [2.32-9.14], p < 0.001)
and inferior scar score (HR 1.27 [1.09-1.49], p = 0.002);
and not LV volumes or sphericity remained significant
predictors of outcomes (C-index 0.77 and chi-square of
overall model 50.17, p < 0.001).
Conclusion
In ICM patients with severe LV dysfunction, degree MR
and myocardial scarring (particularly inferior scar) are
better predictors of long-term outcomes, as compared to
LV volumes, EF or sphericity.Page 3 of 3
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